Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
diclofenac potassium (XP21L)
Placebo
Locations
4
United States
Investigative Site
Austin, Texas, United States
Investigative Site
Houston, Texas, United States
Investigative Site
San Marcos, Texas, United States
Investigative Site
Salt Lake City, Utah, United States
Start Date
September 1, 2006
Primary Completion Date
January 1, 2007
Last Updated
September 21, 2010
NCT06528288
NCT06358040
NCT03230565
NCT06576830
NCT05991453
NCT04144972
Lead Sponsor
Xanodyne Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions